Notice2022-21620
Meeting of the Advisory Committee on Blood and Tissue Safety and Availability
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 5, 2022
Issuing agencies
Health and Human Services Department
Abstract
The U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) will hold a virtual meeting. The meeting will be open to the public via webcast. The committee will discuss and vote on a recommendation related to the implementation of the HIV Organ Policy Equity (HOPE) Act of 2013, pertaining to HIV-positive to HIV- positive organ transplantation.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 192 (Wednesday, October 5, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 192 (Wednesday, October 5, 2022)]
[Notices]
[Pages 60404-60405]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-21620]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Advisory Committee on Blood and Tissue Safety and
Availability
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services is hereby
giving notice that the Advisory Committee on Blood and Tissue Safety
and Availability (ACBTSA) will hold a virtual meeting. The meeting will
be open to the public via webcast. The committee will discuss and vote
on a recommendation related to the implementation of the HIV Organ
Policy Equity (HOPE) Act of 2013, pertaining to HIV-positive to HIV-
positive organ transplantation.
DATES: The meeting will take place virtually on Thursday, November 17,
2022 from approximately 10 a.m.-3 p.m. eastern time (ET). Meeting times
are tentative and subject to change. The confirmed times and agenda
items for the meeting will be posted on the ACBTSA web page at <a href="https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/meetings/2022-11-17/index.html">https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/meetings/2022-11-17/index.html</a> when this information becomes available.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the ACBTSA; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Tower Building, 1101 Wootton Parkway,
Rockville, MD 20852. Email: <a href="/cdn-cgi/l/email-protection#64252726303725240c0c174a030b12"><span class="__cf_email__" data-cfemail="33727071676072735b5b401d545c45">[email protected]</span></a>. Phone: 202-795-7608.
SUPPLEMENTARY INFORMATION: On the day of the meeting, please go to
<a href="https://www.hhs.gov/live/index.html">https://www.hhs.gov/live/index.html</a> to view the meeting. The public
will have an opportunity to present their views to the ACBTSA by
submitting a written public comment. Comments should be pertinent to
the meeting discussion. Persons who wish to provide written public
comment should review instructions at <a href="https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/meetings/2022-11-17/index.html">https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/meetings/2022-11-17/index.html</a> and respond by midnight November 9, 2022, ET. Written
public comments will be accessible to the public on the ACBTSA web page
prior to the meeting.
Background and Authority: The ACBTSA is a discretionary Federal
advisory committee and is governed by the provisions of the Federal
Advisory Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C.
app), which sets forth standards for the formation and use of advisory
committees. The ACBTSA functions to provide advice to the Secretary
through the Assistant Secretary for Health on a range of policy issues
to include: (1) Identification of public health issues through
surveillance of blood and tissue safety issues with national survey and
data
[[Page 60405]]
tools; (2) identification of public health issues that affect
availability of blood, blood products, and tissues; (3) broad public
health, ethical, and legal issues related to the safety of blood, blood
products, and tissues; (4) the impact of various economic factors
(e.g., product cost and supply) on safety and availability of blood,
blood products, and tissues; (5) risk communications related to blood
transfusion and tissue transplantation; and (6) identification of
infectious disease transmission issues for blood, organs, blood stem
cells and tissues. The Committee has met regularly since its
establishment in 1997.
Dated: September 23, 2022.
James J. Berger,
Designated Federal Officer, Advisory Committee on Blood and Tissue
Safety and Availability, Office of Infectious Disease and HIV/AIDS
Policy.
[FR Doc. 2022-21620 Filed 10-4-22; 8:45 am]
BILLING CODE 4150-41-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 5, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.